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Oral Presentations 
New drugs for acute and chronic Hepatitis B Virus (HBV) Infection: from HBV-entry 
inhibition to liver-specific drug targetting  
Urban, Stephan 
Department of Molecular Virology, Im Neuenheimer Feld 350, University of Heidelberg, 69120 Heidelberg, 
Germany 
The currently approved treatment options for chronic hepatitis B either obstruct HBV genome replication 
(nucleoside or non-nucleoside reverse transcriptase (RT) inhibitors) or stimulate innate or adaptive 
immune responses (interferon α (IFNα)). However, although these drugs are capable of reducing serum 
titres by several logs, elimination of the virus is commonly not achieved. Furthermore, prolonged virus 
replication at reduced levels in the presence of RT-inhibitors results in the selection and amplification of 
resistant mutants. This relates to the reservoir function and the high stability of cccDNA, the template of 
HBV transcription which accumulates in the nucleus of infected hepatocytes4. Since reduction of virus 
titres lowers the risk of developing liver damage and hepatocellular carcinoma, prolonged treatment even 
without achieving sustained virological responses is recommended. 
In addition to the recent successes in the development of potent nucleoside analogues showing better 
resistance profiles or INFs with improved pharmacokinetic properties and less side effects, there are 
several promising new compounds that target so far unaddressed replication steps of HBV. One of these 
steps is nucleocapsid assembly which can be efficiently inhibited by a family of small molecules called 
dihydroarylpyrimidines (HAPs)1. HAPs, at low concentrations bind yet unassembled HBV core proteins 
thereby preventing the formation of an RNA-containing nucleocapsid and redirect the complex into a 
proteasome-dependent degradation pathway. Another approach addresses the stability of HBV-specific 
transcripts. Adenoviral transfer of HBV-specific of shRNAs into hepatocytes of HBV transgenic mice 
lead to a profound and sustained reduction of HBV gene expression3.  
We have recently shown that large envelope protein-derived lipopetides efficiently interfere with HBV 
entry into hepatocytes in vitro and in vivo2. The lead substance of these peptides (Myrcludex B) consists 
of the first 47 amino acids of the HBV L-protein and is N-terminally myristoylated. Its IC50 in vitro is 
~200 pM. Pharmacokinetic studies showed that the peptide targets the liver of even non HBV-susceptible 
animals with extraordinary selectivity, suggesting the presence of a species-independent but hepatocyte-
specific receptor. Mutational analyses revealed that both, myristoylation and a conserved seven amino 
acid sequence motif are necessary for liver-targeting. Preclinical toxicology studies of Myrcludex B are 
ongoing and will be presented. Considering the possibility that even under strong suppression of viral 
replication infection of naive hepatocytes takes place, it will be interesting to see whether an entry 
inhibitor is capable of reducing the viral cccDNA in chronically infected patients.  
Beside their direct antiviral activity the strong liver-tropism of non-immunogenic HBV surface protein 
derived lipopetides variants can also target other drugs to the liver. One approach is the delivery of IFNα 
to avoid systemic side effects. First results on the feasibility of this concept will be presented.  
Taken together there are promising new substances under preclinical development. In the near future 
these drugs will hopefully broaden the therapeutic spectrum to treat chronic hepatitis B with increased 
success rates.  
Next Generation Sequencing offers new perspectives in Comparative Genomics of plant 
associated Bacteria 
Kube, Michael 
Max Planck Institute for Molecular Genetics, Ihnestr. 63, 14195 Berlin  
Contact: kube@molgen.mpg.de 
Next Generation Sequencing technologies have started to change genome research. Highly automated 
systems provided by companies like 454 Life Sciences or Illumina introduced a revolution in genome 
research. The power of the new technologies can be characterized by a few catchwords like: comparable 
low costs, high amount of data and short turn around time.  
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However, just a draft sequence can be provided by this approach for the majority of genome projects 
with de novo character in contrast to projects with re-sequencing character. Uncertainties resulting from 
the used technique and/or resulting draft sequences limit the benefit. In consequence, sequence quality 
has to be increased by the combination of new and old technologies. Examples and preliminary results 
from running projects will be presented to illustrate the use and benefit of the new techniques in the 
genome research of plant associated species from the Enterobacteriaceae and Acholeplasmataceae. 
Oral Session I 
Elucidation of the roles of blackcurrant reversion virus and phytoplasma in the etiology of 
full blossom disease in currants 
Spak, Josef, Kubelkova, Darina, Pribylova, Jaroslava, Spakova, Vlastimila, Petrzik, Karel 
Biology Centre v.v.i., Institute of Plant Molecular Biology, Academy of Sciences  
Contact: pribyl@umbr.cas.cz 
To determine the roles of phytoplasmas and Blackcurrant reversion virus (BRV) in the etiology of full 
blossom disease (FBD), we conducted graft and dodder transmission experiments. Scions from FBD 
affected Ribes rubrum were grafted onto red, white and black currants. Red and white cultivars revealed 
symptoms of FBD, whereas blackcurrant displayed symptoms of BRV infection. No differences in 
symptoms were observed between plants infected with BRV only and those infected with BRV and 
phytoplasma. 
Aster yellows phytoplasma subgroup 16SrI-C was transferred from FBDinfected red currants to 
periwinkle, which symptoms of green and yellow petal were observed. Back transmission of 
phytoplasma to currant seedlings of red and black currant was not successful. 
Scions of periwinkle infected with aster yellows phytoplasmas of subgroup 16SrI-C and 16SrI-B, which 
were bottle-, bark-, and approach-grafted onto seedlings of red and black currant resulted in positive but 
symptomless transmission of phytoplasma to red currant. We conclude that FBD symptoms are induced 
by BRV rather than by phytoplasma, which was originally described as the causal agent of FBD. 
This work was supported by grants QH91224 from the Ministry of Agriculture and AV0Z50510513 from 
the Academy of Sciences of the Czech Republic and COST 863 Action. 
The authors thank Prof. A. Bertaccini, University of Bologna, Italy, for recommendations regarding 
phytoplasma detection, Dr. M. Barba, ISPAVE, Rome, Italy, for dodder seeds, Dr. A. Lemmetty, MTT, 
Jokioinen, Finland and Dr. A.T. Jones, SCRI, Scotland for recommendations regarding BRV detection 
and †Ing. R. Karešová, RBIP, Holovousy, Czech Republic for the ´Jonkheer van Tets´ and ´Baldwin´ 
seeds. 
Association of Tomato Rinsgpot Virus, Tobacco Ringspot Virus and Xiphinema 
americanum with a decline of highbush blueberry in New York 
Fuchs, Marc 
Cornell University, Department of Plant Pathology, 630 W. North Street, Geneva, NY 14456, USA Contact: 
mf13@cornell.edu 
A survey of highbush blueberry (Vaccinium corymbosum L.), including some cultivars showing virus-
like symptoms, i.e. stunted growth, chlorotic spots, purple lesions, distorted leaves and defoliated shoots, 
was conducted for the occurrence of viruses in New York. Leaves from symptomatic and 
nonsymptomatic plants were tested for virus infection by enzyme-linked immunosorbent assay using 
specific serological reagents (Bioreba, Reinach, Switzerland). Several samples reacted positively for 
Tobacco ringspot virus (TRSV) and Tomato ringspot virus (ToRSV), two virus species belonging to the 
genus Nepovirus in the family Comoviridae. The occurrence of TRSV and ToRSV was confirmed in 
blueberry leaf samples by reverse transcription-polymerase chain reaction (RT-PCR) or immunocapture-
RT-PCR with appropriate primers to amplify a 310-bp and a 580-bp fragment of the RNA-dependent 
RNA polymerase gene, respectively. Comparative sequence analysis of the viral amplicons of New York 
isolates indicated moderate to high nucleotide sequence identities with corresponding ToRSV and TRSV 
reference strains. Also, analysis of soil samples collected from the root zone of blueberry bushes for the 
occurrence of nematodes indicated the presence of specimens from the Xiphinema americanum group. 
